Health Technology Assessment International

What Health Technology Assessment International does

Health Technology Assessment International (HTAi) is a non-profit, non-partisan professional society legally registered in Alberta, Canada, dedicated to promoting evidence-informed decision-making in health systems worldwide. Founded in 2003 and operating through a fully remote Secretariat in Edmonton (11-50 staff), HTAi serves an international membership spanning academics, public and private organizations, health professionals, students, patients, and citizens working in or affected by health technology assessment.

HTAi delivers programmatic community resources rather than commercial software. Its core offerings include flagship Annual Meetings (with the 2026 Annual Meeting in Istanbul and the 2027 Annual Meeting confirmed for Brussels with KCE, RIZIV/INAMI, and BCCH as co-hosts), regional Policy Forums in Asia, Latin America, and Global editions, Interest Groups covering specialization such as Real-World Evidence & AI, Hospital-Based HTA, Medical Devices, Patient & Citizen Involvement, Ethics, and Information Retrieval, plus the IJTAHC academic journal, an Educational Offers Database, a Presentations Library, a Newcomer's Guide, and ongoing webinar programming on emerging HTA methods including AI-augmented evidence retrieval.

The business model is a community-led professional society motion. Revenue is generated through individual and organizational membership fees (subscription/recurring), registration fees for the Annual Meeting, Policy Forums, Regional Meetings, and educational webinars (transactional), and the IJTAHC journal (subscription/recurring). Distribution occurs through a self-service membership portal on htai.org and event-led engagement managed via eventsair.com. Strategic positioning emphasizes HTAi's neutrality and convening authority, with major HTA agencies (NICE, CADTH, IQWiG, KCE) and large industry participants (Roche, AstraZeneca, Novartis, Pfizer, J&J, Abbott, Medtronic) engaged through the Global Policy Forum and other channels.

Name

Health Technology Assessment International

Legal name

Health Technology Assessment International

Website

https://htai.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Health Technology Assessment International (HTAi) is a Canadian-registered, non-profit professional society for global health technology assessment, serving academics, policymakers, industry, clinicians, students, and patients through annual meetings, policy forums, interest groups, webinars, and the IJTAHC journal.

Ownership category

akta.pro rank

Product category

Professional Society / Health Technology Assessment Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

akta.pro secondary industry

Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL)

Keywords

• Health technology assessment
• Professional society services
• HTA education training
• Healthcare policy research
• Medical technology evaluation

Headquarters

HQ city

Edmonton

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: HTAi generates revenue through individual and organizational membership fees, providing access to resources, networks, and professional development opportunities in the HTA field.
2. Annual Meeting and Event Registrations: Revenue generated from registration fees for Annual Meetings, Policy Forums, Regional Meetings, and educational webinars.
3. IJTAHC Journal: The International Journal of Technology Assessment in Health Care (IJTAHC) serves as the official academic journal of HTAi, providing a forum for sharing ideas, opinions, and activities with the international HTA community.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

HTAi is a non-profit professional society that operates a global membership community for health technology assessment (HTA) practitioners. It delivers its core offering through individual and organizational memberships, international conferences (Annual Meetings), Policy Forums (Asia, Global, Latin America), Interest Groups, educational webinars, the IJTAHC academic journal, and resource libraries (Educational Offers Database, Presentations Library, Newcomer's Guide). Members include academics, public and private organizations, health professionals, students, patients, and citizens engaged in evidence-informed healthcare decision-making.

Product overview

HTAi operates as a professional society offering a portfolio of membership services including Annual Meetings (international conferences in locations like Istanbul 2026 and Brussels 2027), Policy Forums (Asia, Global, Latin America), Interest Groups (communities on topics including AI & Data, Medical Devices, Patient Involvement), Webinars, the IJTAHC academic journal, Educational Offers Database, Presentations Library, and Newcomer's Guide. These services are membership benefits and community resources rather than commercial software products.

Differentiator

Problem solved

Functional benefit

Brands

• IJTAHC (International Journal of Technology Assessment in Health Care): The official academic journal of HTAi, providing a forum for sharing ideas, opinions, and activities with members of the international health technology assessment community.

Products and services

• HTAi Annual Meeting
• HTAi Policy Forums (Asia, Global, Latin America)
• HTAi Interest Groups
• HTAi Webinars
• IJTAHC (International Journal of Technology Assessment in Health Care)
• Educational Offers Database
• Presentations Library
• Newcomer's Guide
• HTAi Membership (Individual and Organizational)

Quantifiable outcome

• Nearly 1000 participants from around the world attend Annual Meetings, sharing cutting-edge research and exploring methodological and policy developments
• +1 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core, supporting and minor.

• KCE (Belgian Health Care Knowledge Centre)coreStrategic or Co-development Partner · 12 June 2027The Belgian Health Care Knowledge Centre (KCE) is partnering with HTAi to host the 2027 Annual Meeting in Brussels, Belgium. KCE is a publicly-funded but independent research centre and advisory body that provides scientific guidance to policymakers on topics related to healthcare, including health services research, HTA, good clinical practice, and methodological research.
• RIZIV/INAMI (National Institute for Health and Disability Insurance)coreStrategic or Co-development Partner · 12 June 2027The National Institute for Health and Disability Insurance (NIHDI/RIZIV/INAMI) is co-hosting the HTAi 2027 Annual Meeting in Brussels. This Belgian public institution organizes and monitors compulsory insurance for medical care and benefits, working on innovative pharmaceutical policy to ensure sustainable accessibility of valuable treatments for patients.
• BCCH (Brussels Centre for Collaboration in Health)supportingStrategic or Co-development Partner · 12 June 2027The Brussels Centre for Collaboration in Health (BCCH) is supporting the HTAi 2027 Annual Meeting in Brussels. BCCH is a non-profit organisation established under Belgian law by RIZIV-INAMI to support the EU HTA Framework Contract Consortium, which brings together over 30 organisations across 22 countries to support collaborative activities under the EU HTA Regulation.
• AbbottminorGTM or Marketing PartnerAbbott is listed as a For Profit member organization of the HTAi Global Policy Forum, participating in strategic discussions about HTA with specific relevance to industry.
• F. Hoffmann-La Roche AGminorGTM or Marketing PartnerRoche is listed as a For Profit member organization of the HTAi Global Policy Forum, participating in high-level dialogue on HTA policy and practice.
• NICE (National Institute for Health and Care Excellence)minorGTM or Marketing PartnerNICE (UK) is listed as a Non-Profit member organization of the HTAi Global Policy Forum, contributing to discussions on health technology assessment policy and practice.
• CADTH (Canada's Drug Agency)minorGTM or Marketing PartnerCADTH (Canada's Drug Agency) is listed as a Non-Profit member organization of the HTAi Global Policy Forum, participating in international HTA policy discussions.
• IQWiG (Institute for Quality and Efficiency in Health Care)minorGTM or Marketing PartnerIQWiG (Germany) is listed as a Non-Profit member organization of the HTAi Global Policy Forum, contributing to discussions on HTA methodology and policy.
• AstraZenecaminorGTM or Marketing PartnerAstraZeneca is listed as a For Profit member organization of the HTAi Global Policy Forum, engaging in policy discussions on health technology assessment.
• Novartis Pharma AGminorGTM or Marketing PartnerNovartis is listed as a For Profit member organization of the HTAi Global Policy Forum, participating in strategic dialogue on HTA policy and practice.
• Pfizer LimitedminorGTM or Marketing PartnerPfizer is listed as a For Profit member organization of the HTAi Global Policy Forum, contributing to discussions on HTA policy and industry engagement.
• Johnson & JohnsonminorGTM or Marketing PartnerJohnson & Johnson is listed as a For Profit member organization of the HTAi Global Policy Forum, engaging in policy discussions related to health technology assessment.
• MedtronicminorGTM or Marketing PartnerMedtronic is listed as a For Profit member organization of the HTAi Global Policy Forum, participating in discussions on HTA policy and medical technology assessment.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• NICE (National Institute for Health and Care Excellence): UK national HTA agency and a listed HTAi Global Policy Forum member; operates in the same field with substantially larger resources and direct policy authority, overlapping with HTAi on methodology and cross-border HTA dialogue.
• Drug Information Association (DIA): Global non-profit membership organization serving professionals in pharmaceutical development, regulatory affairs, and market access — overlapping significantly with HTAi's industry and regulatory audience, with a broader scope beyond HTA.
• AHRQ (Agency for Healthcare Research and Quality): US federal agency producing evidence-based research and HTA-relevant outputs that inform health system decisions; operates at much larger scale with a domestic mandate but participates in international HTA dialogue similar to HTAi's network.
• EUnetHTA / EU HTA Coordination: European network coordinating HTA activities across EU member states under the HTA Regulation; highly comparable mission of cross-border HTA collaboration, with policy backing and institutional funding that HTAi lacks.
• IQWiG (Institute for Quality and Efficiency in Health Care): Germany's federal HTA agency and HTAi Global Policy Forum member; shares HTAi's methodological focus and contributes to international HTA policy dialogue, but is a governmental research institute with a different operating mandate.
• Cochrane: Global non-profit organization producing systematic reviews and evidence synthesis that underpin HTA; shares HTAi's evidence-informed decision-making ethos, international volunteer-driven model, and global community structure, though focused upstream on evidence generation rather than assessment.
• CADTH (Canada's Drug Agency): Canadian HTA agency and HTAi Global Policy Forum member; comparable subject-matter focus and Canadian roots (Edmonton HQ overlaps with HTAi's Alberta registration), but operates as a governmental agency rather than a member society.

Direct peers

• INAHTA (International Network of Agencies for Health Technology Assessment): A membership network of HTA agencies globally that shares HTAi's mission of advancing HTA methodology and international collaboration, overlapping directly in audience and subject matter though organized around agency members rather than individuals.
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research): The most direct peer: a global non-profit professional society serving health economics and outcomes research professionals through membership, conferences, working groups, and a flagship journal — structurally and operationally very similar to HTAi but with adjacent methodological focus.
• Society for Medical Decision Making (SMDM): International academic society focused on health decisions, evidence-based medicine, and health economics — overlapping HTAi's academic and methodological community through shared members, journals, and meetings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/htaiorg
• Facebookfacebook.com/htaiorg
• LinkedInlinkedin.com/company/4795702

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Technology Assessment International